These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 37369911)

  • 1. Consensus on the tertiary prevention of primary liver cancer.
    Nan Y; Xu X; Dong S; Yang M; Li L; Zhao S; Duan Z; Jia J; Wei L; Zhuang H;
    Hepatol Int; 2023 Oct; 17(5):1057-1071. PubMed ID: 37369911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The consensus on tertiary prevention of primary liver cancer (2022 version)].
    Chinese Society of Hepatology, Chinese Medical Association
    Zhonghua Gan Zang Bing Za Zhi; 2022 Aug; 30(8):832-845. PubMed ID: 36207940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consensus on the secondary prevention of primary liver cancer.
    Nan Y; Xu X; Gao Y; Wang R; Li W; Yang M; Liu L; Duan Z; Jia J; Wei L; Zhuang H;
    Hepatol Int; 2021 Dec; 15(6):1289-1300. PubMed ID: 34846705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Consensus on secondary prevention of primary liver cancer (2021 version)].
    Chinese Society of Hepatology, Chinese Medical Association
    Zhonghua Gan Zang Bing Za Zhi; 2021 Mar; 29(3):216-226. PubMed ID: 33902188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma.
    Wang CH; Wey KC; Mo LR; Chang KK; Lin RC; Kuo JJ
    Asian Pac J Cancer Prev; 2015; 16(9):3595-604. PubMed ID: 25987009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tertiary prevention of hepatocellular carcinoma in chronic hepatitis C patients.
    Huang JF; Yeh ML; Yu ML; Dai CY; Huang CF; Huang CI; Tsai PC; Lin PC; Chen YL; Chang WT; Hou NJ; Lin ZY; Chen SC; Chuang WL
    J Gastroenterol Hepatol; 2015 Dec; 30(12):1768-74. PubMed ID: 26094738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
    Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
    J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in prevention and diagnosis of hepatocellular carcinoma.
    Spangenberg HC; Thimme R; Blum HE
    Expert Rev Gastroenterol Hepatol; 2008 Jun; 2(3):425-33. PubMed ID: 19072390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan.
    ; ; ; ; ; ; ; ; ;
    J Formos Med Assoc; 2018 May; 117(5):381-403. PubMed ID: 29074347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expert consensus on clinical diagnosis and treatment of portal hypertension with hepatocellular carcinoma (2022)].
    Chinese Society of Spleen and Portal Hypertension Surgery, Chinese Society of Surgery, Chinese Medical Association
    Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):310-320. PubMed ID: 35272421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update.
    Cong WM; Bu H; Chen J; Dong H; Zhu YY; Feng LH; Chen J;
    World J Gastroenterol; 2016 Nov; 22(42):9279-9287. PubMed ID: 27895416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hepatocellular carcinoma.
    Masuzaki R; Omata M
    Indian J Gastroenterol; 2008; 27(3):113-22. PubMed ID: 18787282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
    Kim BK; Han KH; Ahn SH
    Oncology; 2011; 81 Suppl 1():41-9. PubMed ID: 22212935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus-related hepatocellular carcinoma: primary, secondary, and tertiary prevention.
    Giacomin A; Cazzagon N; Sergio A; Vanin V; Farinati F
    Eur J Cancer Prev; 2011 Sep; 20(5):381-8. PubMed ID: 21540746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.
    Kudo M; Izumi N; Kokudo N; Matsui O; Sakamoto M; Nakashima O; Kojiro M; Makuuchi M;
    Dig Dis; 2011; 29(3):339-64. PubMed ID: 21829027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The progression of hepatitis B- and C-infections to chronic liver disease and hepatocellular carcinoma: presentation, diagnosis, screening, prevention, and treatment of hepatocellular carcinoma.
    Hayashi PH; Di Bisceglie AM
    Med Clin North Am; 2005 Mar; 89(2):345-69. PubMed ID: 15656930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of hepatocellular carcinoma in chronic liver disease: molecular markers and clinical implications.
    Plesch FN; Kubicka S; Manns MP
    Dig Dis; 2001; 19(4):338-44. PubMed ID: 11935094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care.
    McMahon B; Block J; Block T; Cohen C; Evans AA; Hosangadi A; London WT; Sherman M;
    J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26626106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary hepatocellular carcinoma: early diagnosis and importance of screening.
    Christie P
    N Z Med J; 1995 May; 108(999):175-6. PubMed ID: 7753516
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hepatocellular carcinoma].
    Blum HE
    Dtsch Med Wochenschr; 2005 Dec; 130 Suppl 5():S221-3. PubMed ID: 16435716
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.